trial summary · NCT07888257
LIfestyle MEtabotype Study B (LIME-B)
Trial record from the TrialBase DB dataset, status RECRUITING, condition Nutritional and Metabolic Diseases, sponsored by German Institute of Human Nutrition. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Glycemic responses vary significantly among individuals, even when consuming identical foods or meals, but the factors predicting individual glucose responses to food intake remain poorly investigated. The aim of the LIfestyle MEtabotype (LIME) study is to identify lifestyle-related and mechanistic factors which predict individual postprandial glucose fluctuations in individuals with different glycemic status (prediabetes, type 2 diabetes \[T2D\] and absence of prediabetes or T2D), using comprehensive lifestyle characterization and metabolic, molecular and neurocognitive phenotyping. As part of this phenotyping, the LIME study also investigates the role of ketone bodies. Individuals with insulin resistance, prediabetes or T2D often show impaired cerebral glucose utilization. Ketone bodies, such as β-hydroxybutyrate (βHB) may serve as an alternative energy source for the brain. However, how exogenous βHB affects neurocognitive processes and decision-making in individuals with different glycemic status remains poorly understood. This record describes module B of the LIME study. Module B investigates the effects of a single dose of exogenous βHB, compared with a carbohydrate-based placebo drink, on brain structure and function, decision-making behavior and physiological and metabolic responses. Module A comprises a comprehensive lifestyle and metabolic characterization of the same participants and is registered separately as an observational study (NCT07868601). Data from both modules will be integrated in joint analyses.
Source record: https://clinicaltrials.gov/study/NCT07888257
Facts
| registry id | NCT07888257 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Nutritional and Metabolic Diseases |
| sponsor | German Institute of Human Nutrition |
| sponsor class | OTHER |
| enrollment | 300 |
| start date | 2026-10-26 |
| primary completion | 2030-12-31 |
| completion | 2031-12-31 |
| results posted | not reported |
Conditions
- Nutritional and Metabolic Diseases
- Prediabetes
- Type 2 Diabetes
Interventions
- βHB drink (ketone ester)
- Carbohydrate drink
Countries
- Germany
Intervention types: DIETARY_SUPPLEMENT
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.